S. Arbuck

Phase I clinical trial of continuous infusion cyclopentenyl cytosine

A. Chen, J. Grem, C. Allegra, 2004, Cancer Chemotherapy and Pharmacology.

Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP).

L. Pendyala, A. Mittelman, S. Madajewicz, 1983, Cancer treatment reports.

An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix

R. Winn, A. Kudelka, R. Freedman, 1997, Anti-cancer drugs.

Topotecan treatment of adults with primary malignant glioma

R. McLendon, A. Friedman, S. Arbuck, 1999, Cancer.

Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia.

E. Estey, M. Andreeff, S. Arbuck, 1996, Blood.

Phase I study of paclitaxel (P) combined with 14-day topotecan (T) Continuous IV (CIV) infusion in previously treated and untreated patients (PTS)

H. Hochster, A. Chachoua, J. Speyer, 1997 .